Experimental oncornavirus vaccines in the cat

Area of Science:

• Veterinary Virology
• Oncology
• Immunology

Background:

• Feline oncornavirus-mediated diseases pose significant health challenges in cats.
• Developing effective immunoprophylactic strategies is crucial for controlling these oncogenic RNA tumor viruses.

Purpose of the Study:

• To evaluate the efficacy of killed oncornavirus vaccines in preventing feline oncornavirus-associated diseases.
• To investigate the role of maternal antibodies in protecting kittens from oncornavirus infections.

Main Methods:

• Immunization of pregnant queens and kittens with inactivated feline sarcoma virus and feline leukemia virus vaccines.
• Challenging kittens with tumor-forming doses of feline sarcoma virus at different ages.
• Assessing protection by monitoring survival, tumor development, and antibody titers.

Main Results:

• Vaccination of pregnant queens provided significant protection to kittens challenged shortly after birth, with higher maternal antibody titers correlating with better protection.
• Kittens vaccinated directly showed insufficient protection against feline sarcoma virus challenge, indicating age-dependent immune responsiveness.
• Immunization with gamma-irradiated tumor extract successfully protected kittens, inducing both tumor antigen and neutralizing antibodies.

Conclusions:

• Killed virus and tumor vaccines demonstrate potential as immunoprophylactic agents against feline RNA tumor virus oncogenesis.
• Maternal immunization is a viable strategy for protecting neonatal kittens, highlighting the importance of antibody transfer.
• This feline model offers valuable insights for developing similar vaccines for human applications.